Sino Biopharmaceutic (SBMFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 06-2021 | 03-2021 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,180,682 | 1,243,588 | 1,223,924 | 2,328,279 | 2,411,506 |
| Marketable Securities | 639,370 | 374,087 | 371,015 | 351,305 | 300,167 |
| Receivables | 996,466 | 783,690 | 501,626 | 536,082 | 610,841 |
| Inventories | 253,731 | 268,224 | 279,754 | 254,296 | 254,356 |
| Other current assets | 20,027 | 17,877 | 18,020 | 21,428 | 1 |
| TOTAL | $3,483,158 | $3,688,683 | $3,362,292 | $4,395,700 | $4,853,994 |
| Non-Current Assets | |||||
| PPE Net | 1,109,895 | 1,096,456 | 1,089,856 | 1,054,002 | 1,022,182 |
| Investments And Advances | 2,556,271 | 2,705,657 | 1,955,660 | 716,495 | 424,527 |
| Intangibles | 431,336 | 282,193 | 268,423 | 3,065,380 | 3,010,080 |
| Other Non-Current Assets | 1,631,127 | 933,434 | 908,044 | 341,059 | 333,169 |
| TOTAL | $5,728,629 | $5,017,740 | $4,221,983 | $5,176,936 | $4,789,958 |
| Total Assets | $9,211,787 | $8,706,422 | $7,584,275 | $9,572,637 | $9,643,951 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,174,002 | 282,643 | 186,647 | 44,229 | 43,399 |
| Accounts payable and accrued liabilities | 1,797,779 | 1,454,085 | 1,388,434 | 1,353,652 | 1,419,168 |
| Other current liabilities | 1,723 | N/A | N/A | N/A | N/A |
| TOTAL | $3,031,186 | $1,779,103 | $1,598,311 | $1,437,892 | $1,486,475 |
| Non-Current Liabilities | |||||
| Long Term Debt | 139,483 | 971,739 | 1,082,299 | 1,137,764 | 1,146,271 |
| Other Non-Current Liabilities | 39,596 | 927,139 | 855,295 | 877,574 | 888,466 |
| TOTAL | $363,596 | $2,108,524 | $2,151,317 | $2,284,198 | $2,301,424 |
| Total Liabilities | $3,394,782 | $3,887,627 | $3,749,628 | $3,722,091 | $3,787,898 |
| Shareholders' Equity | |||||
| Common Shares | 57,226 | 64,422 | 64,173 | 60,174 | 39,268 |
| Retained earnings | 3,612,764 | N/A | N/A | N/A | 2,254,268 |
| Other shareholders' equity | 2,011,661 | 4,827,373 | 3,843,474 | 5,850,371 | 1,851,080 |
| TOTAL | $5,817,004 | $4,818,795 | $3,834,647 | $5,850,545 | $5,856,053 |
| Total Liabilities And Equity | $9,211,786 | $8,706,422 | $7,584,275 | $9,572,636 | $9,643,951 |